相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。WNT signaling in glioblastoma and therapeutic opportunities
Yeri Lee et al.
LABORATORY INVESTIGATION (2016)
A Novel High Content Imaging-Based Screen Identifies the Anti-Helminthic Niclosamide as an Inhibitor of Lysosome Anterograde Trafficking and Prostate Cancer Cell Invasion
Magdalena L. Circu et al.
PLOS ONE (2016)
ER stress: Autophagy induction, inhibition and selection
Harun-Or Rashid et al.
AUTOPHAGY (2015)
Niclosamide, an anti-helminthic molecule, downregulates the retroviral oncoprotein Tax and pro-survival Bcl-2 proteins in HTLV-1-transformed T lymphocytes
Di Xiang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Niclosamide Analogs for Treatment of Ovarian Cancer
Christen L. Walters Haygood et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2015)
Effect of the JAK2/STAT3 inhibitor SAR317461 on human glioblastoma tumorspheres
Rajesh Mukthavaram et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
被撤回的出版物: Recurrent Glioblastoma: Where we stand(Retracted article. See vol. 6, pg. 153, 2017)
Sanjoy Roy et al.
SOUTH ASIAN JOURNAL OF CANCER (2015)
Multi-targeted therapy of cancer by niclosamide: A new application for an old drug
Yonghe Li et al.
CANCER LETTERS (2014)
Inhibition of Wnt/β-catenin pathway by niclosamide: A therapeutic target for ovarian cancer
Rebecca C. Arend et al.
GYNECOLOGIC ONCOLOGY (2014)
Disruption of STAT3 by Niclosamide Reverses Radioresistance of Human Lung Cancer
Shuo You et al.
MOLECULAR CANCER THERAPEUTICS (2014)
The Anthelmintic Drug Niclosamide Induces Apoptosis, Impairs Metastasis and Reduces Immunosuppressive Cells in Breast Cancer Model
Tinghong Ye et al.
PLOS ONE (2014)
Anticancer Effects of Niclosamide in Human Glioblastoma
Anja Wieland et al.
CLINICAL CANCER RESEARCH (2013)
Alteration of Plasma Membrane Organization by an Anticancer Lysophosphatidylcholine Analogue Induces Intracellular Acidification and Internalization of Plasma Membrane Transporters in Yeast
Ola Czyz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
The role of Stat3 in glioblastoma multiforme
Rodney B. Luwor et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2013)
Niclosamide Overcomes Acquired Resistance to Erlotinib through Suppression of STAT3 in Non-Small Cell Lung Cancer
Rui Li et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Drug Screening Identifies Niclosamide as an Inhibitor of Breast Cancer Stem-Like Cells
Yu-Chi Wang et al.
PLOS ONE (2013)
Inhibition of STAT3 by Niclosamide Synergizes with Erlotinib against Head and Neck Cancer
Rui Li et al.
PLOS ONE (2013)
Cannabidiol, a Non-Psychoactive Cannabinoid Compound, Inhibits Proliferation and Invasion in U87-MG and T98G Glioma Cells through a Multitarget Effect
Marta Solinas et al.
PLOS ONE (2013)
Targeting EGFR for Treatment of Glioblastoma: Molecular Basis to Overcome Resistance
T. E. Taylor et al.
CURRENT CANCER DRUG TARGETS (2012)
Structure-Activity Analysis of Niclosamide Reveals Potential Role for Cytoplasmic pH in Control of Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling
Bruno D. Fonseca et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
STAT3 Inhibition Overcomes Temozolomide Resistance in Glioblastoma by Downregulating MGMT Expression
Shinji Kohsaka et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Growth Inhibition of Ovarian Tumor-Initiating Cells by Niclosamide
Yi-Te Yo et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Niclosamide Is a Proton Carrier and Targets Acidic Endosomes with Broad Antiviral Effects
Andreas Jurgeit et al.
PLOS PATHOGENS (2012)
Therapeutic Strategies to Target Multiple Kinases in Glioblastoma
Sith Sathornsumetee
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2011)
Niclosamide induces mitochondria fragmentation and promotes both apoptotic and autophagic cell death
So Jung Park et al.
BMB REPORTS (2011)
Antihelminth Compound Niclosamide Downregulates Wnt Signaling and Elicits Antitumor Responses in Tumors with Activating APC Mutations
Takuya Osada et al.
CANCER RESEARCH (2011)
Niclosamide: An Established Antihelminthic Drug as a Potential Therapy Against S100A4-Mediated Metastatic Colon Tumors
David M. Helfman
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Insulin-like growth factor-I mediates neuroprotection in proteasome inhibition-induced cytotoxicity in SH-SY5Y cells
Benxu Cheng et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2011)
Proteasome Inhibition Represses Unfolded Protein Response and Nox4, Sensitizing Vascular Cells to Endoplasmic Reticulum Stress-Induced Death
Angelica M. Amanso et al.
PLOS ONE (2011)
Niclosamide Suppresses Cancer Cell Growth By Inducing Wnt Co-Receptor LRP6 Degradation and Inhibiting the Wnt/β-Catenin Pathway
Wenyan Lu et al.
PLOS ONE (2011)
The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation
Michelle C. Mendoza et al.
TRENDS IN BIOCHEMICAL SCIENCES (2011)
Antineoplastic Mechanisms of Niclosamide in Acute Myelogenous Leukemia Stem Cells: Inactivation of the NF-κB Pathway and Generation of Reactive Oxygen Species
Yanli Jin et al.
CANCER RESEARCH (2010)
Survival of Patients with Newly Diagnosed Glioblastoma Treated with Radiation and Temozolomide in Research Studies in the United States
Stuart A. Grossman et al.
CLINICAL CANCER RESEARCH (2010)
Niclosamide Prevents the Formation of Large Ubiquitin-Containing Aggregates Caused by Proteasome Inhibition
Esther Gies et al.
PLOS ONE (2010)
Crosstalk Between the PI3K/mTOR and MEK/ERK Pathways Involved in the Maintenance of Self-Renewal and Tumorigenicity of Glioblastoma Stem-Like Cells
Jun Sunayama et al.
STEM CELLS (2010)
Identification of Niclosamide as a New Small-Molecule Inhibitor of the STAT3 Signaling Pathway
Xiaomei Ren et al.
ACS MEDICINAL CHEMISTRY LETTERS (2010)
The Anti-Helminthic Niclosamide Inhibits Wnt/Frizzled1 Signaling
Minyong Chen et al.
BIOCHEMISTRY (2009)
Targeted Therapies for Malignant Glioma Progress and Potential
Ronald W. Mercer et al.
BIODRUGS (2009)
Inhibition of Akt inhibits growth of glioblastoma and glioblastoma stem-like cells
Gary L. Gallia et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Suppression of Cancer Cell Growth by Promoting Cyclin D1 Degradation
Jing Shan et al.
MOLECULAR CELL (2009)
Screen for Chemical Modulators of Autophagy Reveals Novel Therapeutic Inhibitors of mTORC1 Signaling
Aruna D. Balgi et al.
PLOS ONE (2009)
STAT3 Is Required for Proliferation and Maintenance of Multipotency in Glioblastoma Stem Cells
Maureen M. Sherry et al.
STEM CELLS (2009)
Autophagy and the ubiquitin-proteasome system: Collaborators in neuroprotection
Natalia B. Nedelsky et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2008)
Malignant gliomas in adults
Patrick Y. Wen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Role of hyaluronan in glioma invasion
Jong Bae Park et al.
CELL ADHESION & MIGRATION (2008)
Linking of autophagy to ubiquitin-proteasome system is important for the regulation of endoplasmic reticulum stress and cell viability
Wen-Xing Ding et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
AKT1, AKT2 and AKT3-dependent cell survival is cell line-specific and knockdown of all three isoforms selectively induces apoptosis in 20 human tumor cell lines
Sandra Koseoglu et al.
CANCER BIOLOGY & THERAPY (2007)
Bortezomib inhibits PKR-like endoplasmic reticulum (ER) kinase and induces apoptosis via ER stress in human pancreatic cancer cells
ST Nawrocki et al.
CANCER RESEARCH (2005)
Regulation of apoptosis proteins in cancer cells by ubiquitin
HG Zhang et al.
ONCOGENE (2004)
Regulation of apoptosis by ubiquitination
JC Lee et al.
IMMUNOLOGICAL REVIEWS (2003)
Inhibition of constitutively active Stat3 suppresses proliferation and induces apoptosis in glioblastoma multiforme cells
SO Rahaman et al.
ONCOGENE (2002)
Impairment of the ubiquitin-proteasome system by protein aggregation
NF Bence et al.
SCIENCE (2001)
Proliferation, cell cycle and apoptosis in cancer
GI Evan et al.
NATURE (2001)
分享论文
